News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
809,549 Results
Type
Article (75092)
Company Profile (437)
Press Release (733995)
Multimedia
Podcasts (138)
Webinars (23)
Section
Business (223040)
Career Advice (3031)
Deals (38442)
Drug Delivery (128)
Drug Development (88847)
Employer Resources (189)
FDA (17883)
Job Trends (16457)
News (380269)
Policy (37749)
Tag
Academia (2976)
Academic (1)
Accelerated approval (17)
Adcomms (34)
Allergies (118)
Alliances (55262)
ALS (135)
Alzheimer's disease (1641)
Antibody-drug conjugate (ADC) (198)
Approvals (17876)
Artificial intelligence (408)
Autoimmune disease (47)
Automation (23)
Bankruptcy (394)
Best Places to Work (12366)
BIOSECURE Act (22)
Biosimilars (145)
Biotechnology (295)
Bladder cancer (118)
Brain cancer (45)
Breast cancer (430)
Cancer (3499)
Cardiovascular disease (308)
Career advice (2558)
Career pathing (35)
CAR-T (226)
CDC (47)
Cell therapy (608)
Cervical cancer (29)
Clinical research (72987)
Collaboration (1276)
Company closure (4)
Compensation (860)
Complete response letters (50)
COVID-19 (2935)
CRISPR (77)
C-suite (501)
Cystic fibrosis (130)
Data (3738)
Decentralized trials (2)
Denatured (42)
Depression (96)
Diabetes (415)
Diagnostics (6948)
Digital health (29)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (186)
Drug pricing (166)
Drug shortages (34)
Duchenne muscular dystrophy (182)
Earnings (93584)
Editorial (52)
Employer branding (23)
Employer resources (162)
Events (126221)
Executive appointments (952)
FDA (20089)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1114)
Gene editing (164)
Generative AI (30)
Gene therapy (486)
GLP-1 (986)
Government (5152)
Grass and pollen (7)
Guidances (333)
Healthcare (20466)
HIV (46)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (222)
Immuno-oncology (17)
Indications (46)
Infectious disease (3152)
Inflammatory bowel disease (179)
Inflation Reduction Act (11)
Influenza (85)
Intellectual property (160)
Interviews (558)
IPO (17543)
IRA (56)
Job creations (4505)
Job search strategy (2126)
Kidney cancer (14)
Labor market (65)
Layoffs (612)
Leadership (29)
Legal (9429)
Liver cancer (89)
Longevity (12)
Lung cancer (509)
Lymphoma (250)
Machine learning (21)
Management (63)
Manufacturing (542)
MASH (117)
Medical device (14523)
Medtech (14541)
Mergers & acquisitions (21721)
Metabolic disorders (1062)
Multiple sclerosis (117)
NASH (23)
Neurodegenerative disease (180)
Neuropsychiatric disorders (48)
Neuroscience (2525)
NextGen: Class of 2025 (7299)
Non-profit (5028)
Now hiring (54)
Obesity (536)
Opinion (289)
Ovarian cancer (114)
Pain (152)
Pancreatic cancer (146)
Parkinson's disease (213)
Partnered (25)
Patents (381)
Patient recruitment (267)
Peanut (56)
People (63842)
Pharmaceutical (92)
Pharmacy benefit managers (25)
Phase I (22578)
Phase II (31833)
Phase III (23918)
Pipeline (2441)
Policy (273)
Postmarket research (3259)
Preclinical (10115)
Press Release (72)
Prostate cancer (171)
Psychedelics (49)
Radiopharmaceuticals (280)
Rare diseases (597)
Real estate (6925)
Recruiting (73)
Regulatory (26421)
Reports (55)
Research institute (2657)
Resumes & cover letters (483)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (184)
Series B (137)
Service/supplier (21)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (40)
Startups (4090)
State (2)
Stomach cancer (17)
Supply chain (93)
Tariffs (82)
The Weekly (94)
Vaccines (1001)
Venture capital (63)
Weight loss (367)
Women's health (54)
Worklife (21)
Date
Today (115)
Last 7 days (452)
Last 30 days (2343)
Last 365 days (32904)
2025 (22949)
2024 (37429)
2023 (42274)
2022 (53660)
2021 (58387)
2020 (57172)
2019 (50406)
2018 (38238)
2017 (35981)
2016 (36635)
2015 (42744)
2014 (37292)
2013 (33438)
2012 (35214)
2011 (35440)
2010 (34486)
Location
Africa (1063)
Alabama (76)
Alaska (7)
Arizona (283)
Arkansas (13)
Asia (46707)
Australia (8025)
California (8827)
Canada (2684)
China (828)
Colorado (370)
Connecticut (392)
Delaware (234)
Europe (107096)
Florida (1307)
Georgia (302)
Hawaii (3)
Idaho (65)
Illinois (746)
India (42)
Indiana (422)
Iowa (18)
Japan (266)
Kansas (119)
Kentucky (34)
Louisiana (18)
Maine (75)
Maryland (1199)
Massachusetts (6577)
Michigan (277)
Minnesota (533)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (100)
New Hampshire (74)
New Jersey (2437)
New Mexico (31)
New York (2410)
North Carolina (1332)
North Dakota (10)
Northern California (3945)
Ohio (274)
Oklahoma (17)
Oregon (41)
Pennsylvania (1843)
Puerto Rico (18)
Rhode Island (41)
South America (1453)
South Carolina (45)
South Dakota (1)
Southern California (3375)
Tennessee (141)
Texas (1361)
United States (32545)
Utah (263)
Virginia (226)
Washington D.C. (82)
Washington State (738)
West Virginia (4)
Wisconsin (88)
809,549 Results for "huntingdon s disease research group chdi foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuraLight and CHDI Foundation Collaborate to Develop Precision Eye Movement Biomarkers for Huntington’s Disease
September 10, 2025
·
2 min read
Press Releases
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 28, 2025
·
4 min read
Business
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Evotec SE has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. CHDI is a privately funded nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease.
May 28, 2024
·
5 min read
Press Releases
Hope Biosciences Research Foundation Opens Enrollment for FDA-Authorized Crohn’s Disease Stem Cell Trial
August 20, 2025
·
2 min read
Government
New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit
George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a second FDA division to his portfolio after Vinay Prasad’s sudden departure.
July 30, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Evestia Clinical to merge with Atlantic Research Group
July 16, 2025
·
5 min read
Press Releases
Lung Cancer Research Foundation Expands Scientific Advisory Board
August 20, 2025
·
9 min read
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Aplos Analytics and Metrum Research Group Announce Strategic Partnership to Integrate Aplos NCA into Metworx Platform
September 2, 2025
·
1 min read
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
Societies, including the American Academy of Pediatrics, allege that Kennedy’s directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and healthy children puts these vulnerable groups at risk of serious illness.
July 8, 2025
·
2 min read
·
Tristan Manalac
1 of 80,955
Next
